Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueTax ProvisionsTax Rate
Others
Ratios

Metlife (MET-PA) EBIT (2016 - 2025)

Historic EBIT for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to $6.1 billion.

  • Metlife's EBIT rose 1649.13% to $6.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 billion, marking a year-over-year increase of 379.58%. This contributed to the annual value of $21.3 billion for FY2024, which is 685.65% up from last year.
  • Per Metlife's latest filing, its EBIT stood at $6.1 billion for Q3 2025, which was up 1649.13% from $5.7 billion recorded in Q2 2025.
  • In the past 5 years, Metlife's EBIT registered a high of $6.1 billion during Q3 2025, and its lowest value of $3.6 billion during Q2 2022.
  • Its 5-year average for EBIT is $5.0 billion, with a median of $5.2 billion in 2024.
  • As far as peak fluctuations go, Metlife's EBIT skyrocketed by 7360.34% in 2021, and later tumbled by 3561.42% in 2022.
  • Metlife's EBIT (Quarter) stood at $5.2 billion in 2021, then fell by 14.7% to $4.5 billion in 2022, then grew by 20.21% to $5.4 billion in 2023, then grew by 0.73% to $5.4 billion in 2024, then rose by 12.65% to $6.1 billion in 2025.
  • Its EBIT stands at $6.1 billion for Q3 2025, versus $5.7 billion for Q2 2025 and $4.9 billion for Q1 2025.